Freenome, Inc. Investment Income, Nonoperating
Freenome, Inc. (FRNM) reported Investment Income, Nonoperating of $807.09 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2026-05-13
- Freenome, Inc. investment income, nonoperating for the quarter ending 2026-03-31 was $807.09K, a 13.64% decline year-over-year.
- Freenome, Inc. investment income, nonoperating for the quarter ending 2025-09-30 was $1.00M, a 15.01% decline year-over-year.
- Freenome, Inc. investment income, nonoperating for the quarter ending 2025-06-30 was $948.04K, a 352.68% increase year-over-year.
- Freenome, Inc. investment income, nonoperating for the quarter ending 2025-03-31 was $934.51K.
| Period end | Investment Income, Nonoperating 0 month | Investment Income, Nonoperating 3 month | Investment Income, Nonoperating 6 month | Investment Income, Nonoperating 9 month | Investment Income, Nonoperating 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $807.09K 10-Q · filed 2026-05-13 | ||||
| 2025-09-30 | $1.00M 10-Q · filed 2025-11-13 | $1.95M derived: sum of 2 quarters · filed 2025-11-13 | $2.88M 10-Q · filed 2025-11-13 | $3.90M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-06-30 | $948.04K 10-Q · filed 2025-08-13 | $1.88M 10-Q · filed 2025-08-13 | $2.90M derived: sum of 3 quarters · filed 2026-05-13 | $4.08M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-03-31 | $934.51K 10-Q · filed 2026-05-13 | $1.95M derived: sum of 2 quarters · filed 2026-05-13 | $3.13M derived: sum of 3 quarters · filed 2026-05-13 | $3.34M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $1.02M derived: 10-K 9 month − 10-Q 6 month · filed 2025-03-19 | $2.19M derived: sum of 2 quarters · filed 2025-11-13 | $2.40M 10-K · filed 2025-03-19 | ||
| 2024-09-30 | $1.18M 10-Q · filed 2025-11-13 | $1.39M 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $209.43K 10-Q · filed 2025-08-13 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |